|
[1]ZHANG J, WANG QX, MA X.Advances in immunological treatment of autoimmune hepatitis[J].J Clin Hepatol, 2016, 32 (10) :1874-1877. (in Chinese) 张琚, 王绮夏, 马雄.自身免疫性肝炎免疫学治疗进展[J].临床肝胆病杂志, 2016, 32 (10) :1874-1877.
|
|
[2]WING K, ONISHI Y, PRIETO-MARTIN P, et al.CTLA-4 control over Foxp3+regulatory T cell function[J].Science, 2008, 322 (5899) :271-275.
|
|
[3]CAMISASCHI C, CASATI C, RINI F, et al.LAG-3 expression defines a subset of CD4 (+) CD25 (high) Foxp3 (+) regulatory T cells that are expanded at tumor sites[J].Immunol, 2010, 184 (11) :6545-6551.
|
|
[4]LEVINGS MK, SANGREGORIO R, SARTIRANA C, et al.Human CD25+CD4+T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells[J].J Exp Med, 2002, 196 (10) :1335-1346.
|
|
[5]HOEMING A, KOSS K, DATTA D, et al.Subsets of human CD4+regulatory T cells express the peripheral homing receptor CXCR3[J].Eur J Immunol, 2011, 41 (8) :2291-2302.
|
|
[6]ZHANG X, KELARIA S, KERSTETTER J, et al.The functional and prognostic implications of regulatory T cells in colorectal carcinoma[J].J Gastrointest Oncol, 2015, 6 (3) :307-313.
|
|
[7]ZHANG D, CHEN YT, LI RR, et al.Analysis on mechanism of CD4+CD25+Treg cell-mediated tumor Immune[J].Chin Arch Tradit Chin Med, 2014, 32 (12) :2286-2288. (in Chinese) 张荻, 陈宜恬, 李荣荣, 等.CD4+CD25+Treg细胞介导的肿瘤免疫机制探析[J].中华中医药学刊, 2014, 32 (12) :2286-2288.
|
|
[8]LI Z, LI D, TSUN A, et al.FOXP3+regulatory T cells and their functional regulation[J].Cell Mol Immunol, 2015, 12 (5) :558-565.
|
|
[9]YUKSEL M, XIAO X, TAI N, et al.The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model[J].Clin Exp Immunol, 2016, 186 (2) :164-176.
|
|
[10]AN HAACK I, DERKOW K, RIEHN M, et al.The role of regulatory CD4 T cells in maintaining tolerance in a mouse model of autoimmune hepatitis[J].PLo S One, 2015, 10 (11) :1371-1387.
|
|
[11]PEISELER M, SEBODE M, FRANKE B, et al.FOXP3+regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency[J].J Hepatol, 2012, 57 (1) :125-132.
|
|
[12]LAPIERRE P, BELAND K, YANG R, et al.Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance[J].Hepatology, 2013, 57 (1) :217-227.
|
|
[13]TAUBERT R, HARDTKE-WOLENSKI M, NOYAN F, et al.Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies[J].J Hepatol, 2014, 61 (5) :1106-1114.
|
|
[14]BEHAIRY BE, EL-ARABY HA, ABD EL KADER HH, et al.Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis[J].Ann Hepatol, 2016, 15 (5) :682-690.
|
|
[15]DIESTELHORST J, JUNGE N, SCHLUE J, et al.Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy[J].PLo S One, 2017, 2015:461294.
|
|
[16]LI YL, ZHAO Y, YAN HP.Evolution of regulatory T cells in pathogenesis of autoimmune hepatitis[J].J Clin Hepatol, 2012, 28 (5) :332-334. (in Chinese) 李艳丽, 赵艳, 闫惠平.CD4+CD25+调节性T细胞在自身免疫性肝炎发病机制中的作用[J].临床肝胆病杂志, 2012, 28 (5) :332-334.
|
|
[17]CIOFANI M, MADAR A, GALAN C, et al.A validated regulatory network for Th17 cell specification[J].Cell, 2012, 151 (2) :289-303.
|
|
[18]IVANOV II, ZHOU L, LITTMAN DR.Transcriptional regulation of Th17 cell differentiation[J].Semin Immunol, 2007, 19 (6) :409-4l7.
|
|
[19]TZARTOS JS, FRIESE MA, CRANER MJ, et al.Interleukin-17production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis[J].Am J Pathol, 2008, 172 (1) :146-155.
|
|
[20]LOWES MA, KIKUCHI T, FUENTES-DUCULAN J, et al.Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells[J].J Invest Dermotal, 2008, 128 (5) :1207-1211.
|
|
[21]AZIZI G, JADIDI-NIARAGH F, MIRSHAFIEY A.Th17 cells in immunopathogenesis and treatment of rheumatoid arthritis[J].Int J Rheum Dis, 2013, 16 (3) :243-253.
|
|
[22]ZHANG H, BERNUZZI F, LIEO A, et al.Therapeutic potential of IL-17-mediated signaling pathway in autoimmune liver diseases[J].Mediators Inflamm, 2015, 2015:436450.
|
|
[23]ZOU T, QIN AL, FENG TT, et al.Effect of Th17/Treg cells on the activity and prognosis of autoimmune liver diseases[J].Guangdong Med J, 2016, 37 (9) :1337-1340. (in Chinese) 邹婷, 秦爱兰, 冯婷婷, 等.Th17/Treg细胞对自身免疫性肝病的活动性及预后的影响[J].广东医学, 2016, 37 (9) :1337-1340.
|
|
[24]ZHOU L, LOPES JE, CHONG MM, et al.TGF-beta-induced Foxp3 inhibits T (H) 17 cell differentiation by antagonizing RORgammat function[J].Nature, 2008, 453 (7192) :236-240.
|
|
[25]NOACK M, MIOSSEC P.Th17 and regulatory T cell balance in autoimmune and inflammatory diseases[J].Autoimmun Rev, 2014, 13 (6) :668-677.
|
|
[26]LI P, SPOLSKI R, LIAO W, et al.Complex interactions of transcription factors in mediating cytokine biology in T cells[J].Immunol Rev, 2014, 261 (1) :141-156.
|
|
[27]WANG J, WANG XL, XI XL.Expression of Th17 and Treg cells and related cytokines in the peripheral blood of patients with autoimmune hepatitis[J].J Clin Res, 2017, 34 (4) :812-814. (in Chinese) 王君, 王学良, 席新龙.Th17细胞和Treg及相关细胞因子在自身免疫性肝炎患者外周血中的表达[J].医学临床研究, 2017, 34 (4) :812-814.
|
|
[28]GRANT CR, LIBERAL R, HOLDER BS, et al.Dysfunctional CD39 (POS) regulatory T cells and aberrant controlof T-helper type 17 cells in autoimmune hepatitis[J].Hepatology, 2014, 59 (3) :1007-1015.
|
|
[29]ARTERBERY AS, OSAFO-ADDO A, AVITZUR Y, et al.Production of proinflammatory cytokines by monocytes in liver-transplanted recipients with de novo autoimmune hepatitis is enhanced and induced TH1-like regulatory T cells[J].J Imnunol, 2016, 196 (10) :4040-4051.
|
|
[30]LONGHI MS, MA Y, GRANT CR, et al.T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile[J].J Autoimmun, 2013, 41:146-151.
|
|
[31]LIBERAL R, GRANT CR, YUKSEL M, et al.Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis[J].Hepatology, 2017, 66 (5) :1570-1584.
|
|
[32]WEBB G, CHEN YY, LI KK, et al.Single-gene association between GATA-2 and autoimmune hepatitis:A novel genetic insight highlighting immunologic pathways to disease[J].J Hepatol, 2016, 64 (5) :1190-1193.
|
|
[33]LAURANCE A, TATO CM, DAVIDSON TS, et al.Interleukin-2singaling via STAT5 constrains T helper 17 cell generation[J].Immunity, 2007, 26 (3) :371-381.
|
|
[34]CHEN Y, FANG J, CHEN X, et al.Effects of the Treg/Th17 cell balance and their associated cytokines in patients with hepatitis B infection[J].Exp Ther Med, 2015, 9 (2) :573-578.
|
|
[35]LIU B, GAO W, ZHANG L, et al.Th17/Treg imbalance and increased interleukin-21 are associated with liver injury in patients with chronic severe hepatitis B[J].Int Immunopharmacol, 2017, 1 (46) :48-55.
|
|
[36]LI Z, YANG TT, LI WZ, et al.Studies on the population of Th17and Treg cells and the expression of the correlated cytokines in SLE patients[J].Chin J Lab Diag, 2015, 19 (2) :253-255. (in Chinese) 李志, 杨婷婷, 李文哲, 等.系统性红斑狼疮患者外周血Th17与Treg细胞及相关细胞因子表达的研究[J].中国实验诊断学, 2015, 19 (2) :253-255.
|
|
[37]WANG L, DU H, LIU Y, et al.Chinese medicine Bu Xu Hua Yu recipe for the regulation of Treg/Th17 ratio imbalance in autoimmune hepatitis[J].Evid Based Complement Alternat Med, 2015, 2015:461294.
|
|
[38]HOLDER BS, GRANT CR, LIBERAL R, et al.Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2[J].J Autoimmun, 2014, 53:26-32.
|
DownLoad: